Sexually Transmitted Diseases Diagnostics Market is estimated to increase at a Compounded Annual Growth Rate of 6.1% CAGR over the forecast period from 2024 to 2030
The Sexually Transmitted Diseases Diagnostics Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Disease (CT/NG, Gonorrhea, HIV/AIDS, Genital Herpes, Hepatitis B, Syphilis, Mycoplasma Genitalium, Genital Warts, Candidal Vaginitis, Trichomoniasis, Bacterial Vaginosis, HPV, Others), By Test (Culture/Isolation Of Organisms, Molecular Test, Immunology Assay, Others), By Device (Laboratory Devices, Point Of Care (Poc) Devices), By End-User (Laboratory, Point of Care (POC)).
An Introduction to Sexually Transmitted Diseases Diagnostics Market in 2024
In 2024, the market for sexually transmitted diseases (STDs) diagnostics remains crucial for the timely detection and management of infections, contributing to public health efforts to reduce transmission rates and mitigate the impact of STDs on individuals and communities. STD diagnostics encompass a variety of tests, including molecular assays, serological tests, nucleic acid amplification tests (NAATs), and point-of-care (POC) tests, designed to detect the presence of pathogens such as Chlamydia trachomatis, Neisseria gonorrhoeae, human immunodeficiency virus (HIV), and herpes simplex virus (HSV). With advancements in technology, STD diagnostics offer improved sensitivity, specificity, and turnaround times, enabling rapid identification of infections and prompt initiation of treatment. Moreover, the market is influenced by efforts to expand access to testing services, increase awareness of STD prevention and screening guidelines, and integrate STD testing into routine healthcare visits and community-based outreach programs, addressing the diverse needs and challenges in STD prevention and control.
Market Trend: Rising Incidence and Awareness of Sexually Transmitted Diseases (STDs)
A significant trend in the sexually transmitted diseases (STDs) diagnostics market is the rising incidence and awareness of STDs globally. Despite efforts to prevent and control STDs, their prevalence continues to increase, fueled by factors such as changes in sexual behaviors, inadequate access to healthcare, limited screening programs, and the emergence of drug-resistant strains. Additionally, heightened awareness and destigmatization efforts surrounding sexual health have led to more individuals seeking testing and diagnosis for STDs. This trend underscores the importance of early detection and prompt treatment of STDs to prevent complications, reduce transmission rates, and improve public health outcomes. As the burden of STDs grows, there is an increasing demand for innovative diagnostic solutions that enable accurate and timely detection of infections, driving market growth and investment in STDs diagnostics technologies, products, and services.
Market Driver: Public Health Initiatives and Screening Programs
A primary driver propelling the sexually transmitted diseases (STDs) diagnostics market forward is the implementation of public health initiatives and screening programs. Recognizing the significant health and economic burden posed by STDs, governments, healthcare organizations, and advocacy groups worldwide are prioritizing efforts to enhance STD prevention, screening, and treatment services. Public health initiatives such as education campaigns, community outreach programs, and free or subsidized STD testing clinics aim to raise awareness, promote safer sexual practices, and increase access to diagnostic testing for individuals at risk of STDs. Furthermore, the integration of STD screening into routine healthcare visits, prenatal care services, and adolescent health programs helps identify infections early and link affected individuals to appropriate care and treatment. This driver highlights the crucial role of public health interventions in driving demand for STDs diagnostics, supporting market growth, and addressing the unmet needs of populations affected by STDs.
Market Opportunity: Development of Point-of-Care Testing Solutions
An opportunity within the sexually transmitted diseases (STDs) diagnostics market lies in the development of point-of-care testing solutions. While traditional laboratory-based STD testing methods provide accurate results, they often require centralized facilities, specialized equipment, and trained personnel, leading to delays in diagnosis and treatment. Point-of-care testing (POCT) solutions offer the advantage of rapid, decentralized testing at the point of patient care, enabling timely diagnosis, treatment initiation, and partner notification. POCT devices for STDs can include rapid immunoassays, nucleic acid amplification tests (NAATs), and molecular diagnostic platforms that provide on-the-spot results within minutes to hours. By developing user-friendly, cost-effective, and reliable POCT solutions for STDs, manufacturers can address barriers to access, improve patient outcomes, and reduce the spread of infections. Additionally, POCT devices offer opportunities for integration with telemedicine platforms, electronic health records (EHRs), and public health surveillance systems, enhancing connectivity and data-sharing capabilities across healthcare networks. This opportunity for innovation and expansion in POCT for STDs enables companies to meet the growing demand for accessible, efficient, and patient-centered diagnostic testing solutions in the fight against STDs.
Sexually Transmitted Diseases (STD) Diagnostics Market Share Analysis: Molecular Test
The fast-growing segment in the Sexually Transmitted Diseases (STD) Diagnostics Market is Molecular Test. Molecular tests have gained prominence in STD diagnostics due to their high sensitivity and specificity in detecting pathogens responsible for various sexually transmitted diseases. These tests utilize nucleic acid amplification techniques like PCR (Polymerase Chain Reaction) to detect the genetic material of pathogens such as Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), HIV/AIDS, Hepatitis B, and others. Molecular tests offer rapid and accurate results, enabling timely diagnosis and appropriate management of STDs. Moreover, advancements in molecular diagnostic technologies have led to the development of multiplex assays capable of detecting multiple pathogens simultaneously, further enhancing the efficiency of STD diagnosis. As a result of these advantages, the molecular test segment is experiencing rapid growth in the STD diagnostics market, with increasing adoption across laboratories and point-of-care settings.
Sexually Transmitted Diseases Diagnostics Competitive Analysis
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAbbott Laboratories, bioMérieux SA, Bi-Rad Laboratories Inc, Danaher Corp, DiaSorin S.p.A, F. Hoffmann-La Roche Ltd, Grifols S.A., Hologic Inc, QIAGEN NV, Quidel Corp, Thermo Fisher Scientific Inc
Sexually Transmitted Diseases Diagnostics Market Segmentation
By Disease
CT/NG
Gonorrhea
HIV/AIDS
Genital Herpes
Hepatitis B
Syphilis
Mycoplasma Genitalium
Genital Warts
Candidal Vaginitis
Trichomoniasis
Bacterial Vaginosis
HPV
Others
By Test
Culture/Isolation Of Organisms
Molecular Test
Immunology Assay
Others
By Device
Laboratory Devices
-Thermal Cyclers – PCR
-Lateral Flow Readers
-Flow Cytometers
-Absorbance Microplate Reader
-Differential Light Scattering Machines
Point Of Care (Poc) Devices
-Phone Chips (Microfluidics + ICT)
-Portable/Bench Top/Rapid Diagnostic Kits
By End-User
Laboratory
-Commerical/Private Labs
-Public Health Labs
Point of Care (POC)
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Sexually Transmitted Diseases Diagnostics Market Companies
Abbott Laboratories
bioMérieux SA
Bi-Rad Laboratories Inc
Danaher Corp
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Grifols S.A.
Hologic Inc
QIAGEN NV
Quidel Corp
Thermo Fisher Scientific Inc
Reasons to Buy the Sexually Transmitted Diseases Diagnostics Market Study
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Sexually Transmitted Diseases Diagnostics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Sexually Transmitted Diseases Diagnostics Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Sexually Transmitted Diseases Diagnostics Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Sexually Transmitted Diseases Diagnostics Market Size Outlook, $ Million, 2021 to 2030
3.2 Sexually Transmitted Diseases Diagnostics Market Outlook by Type, $ Million, 2021 to 2030
3.3 Sexually Transmitted Diseases Diagnostics Market Outlook by Product, $ Million, 2021 to 2030
3.4 Sexually Transmitted Diseases Diagnostics Market Outlook by Application, $ Million, 2021 to 2030
3.5 Sexually Transmitted Diseases Diagnostics Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Sexually Transmitted Diseases Diagnostics Industry
4.2 Key Market Trends in Sexually Transmitted Diseases Diagnostics Industry
4.3 Potential Opportunities in Sexually Transmitted Diseases Diagnostics Industry
4.4 Key Challenges in Sexually Transmitted Diseases Diagnostics Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Sexually Transmitted Diseases Diagnostics Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Sexually Transmitted Diseases Diagnostics Market Outlook by Segments
7.1 Sexually Transmitted Diseases Diagnostics Market Outlook by Segments, $ Million, 2021- 2030
By Disease
CT/NG
Gonorrhea
HIV/AIDS
Genital Herpes
Hepatitis B
Syphilis
Mycoplasma Genitalium
Genital Warts
Candidal Vaginitis
Trichomoniasis
Bacterial Vaginosis
HPV
Others
By Test
Culture/Isolation Of Organisms
Molecular Test
Immunology Assay
Others
By Device
Laboratory Devices
-Thermal Cyclers – PCR
-Lateral Flow Readers
-Flow Cytometers
-Absorbance Microplate Reader
-Differential Light Scattering Machines
Point Of Care (Poc) Devices
-Phone Chips (Microfluidics + ICT)
-Portable/Bench Top/Rapid Diagnostic Kits
By End-User
Laboratory
-Commerical/Private Labs
-Public Health Labs
Point of Care (POC)
8 North America Sexually Transmitted Diseases Diagnostics Market Analysis and Outlook To 2030
8.1 Introduction to North America Sexually Transmitted Diseases Diagnostics Markets in 2024
8.2 North America Sexually Transmitted Diseases Diagnostics Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Sexually Transmitted Diseases Diagnostics Market size Outlook by Segments, 2021-2030
By Disease
CT/NG
Gonorrhea
HIV/AIDS
Genital Herpes
Hepatitis B
Syphilis
Mycoplasma Genitalium
Genital Warts
Candidal Vaginitis
Trichomoniasis
Bacterial Vaginosis
HPV
Others
By Test
Culture/Isolation Of Organisms
Molecular Test
Immunology Assay
Others
By Device
Laboratory Devices
-Thermal Cyclers – PCR
-Lateral Flow Readers
-Flow Cytometers
-Absorbance Microplate Reader
-Differential Light Scattering Machines
Point Of Care (Poc) Devices
-Phone Chips (Microfluidics + ICT)
-Portable/Bench Top/Rapid Diagnostic Kits
By End-User
Laboratory
-Commerical/Private Labs
-Public Health Labs
Point of Care (POC)
9 Europe Sexually Transmitted Diseases Diagnostics Market Analysis and Outlook To 2030
9.1 Introduction to Europe Sexually Transmitted Diseases Diagnostics Markets in 2024
9.2 Europe Sexually Transmitted Diseases Diagnostics Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Sexually Transmitted Diseases Diagnostics Market Size Outlook by Segments, 2021-2030
By Disease
CT/NG
Gonorrhea
HIV/AIDS
Genital Herpes
Hepatitis B
Syphilis
Mycoplasma Genitalium
Genital Warts
Candidal Vaginitis
Trichomoniasis
Bacterial Vaginosis
HPV
Others
By Test
Culture/Isolation Of Organisms
Molecular Test
Immunology Assay
Others
By Device
Laboratory Devices
-Thermal Cyclers – PCR
-Lateral Flow Readers
-Flow Cytometers
-Absorbance Microplate Reader
-Differential Light Scattering Machines
Point Of Care (Poc) Devices
-Phone Chips (Microfluidics + ICT)
-Portable/Bench Top/Rapid Diagnostic Kits
By End-User
Laboratory
-Commerical/Private Labs
-Public Health Labs
Point of Care (POC)
10 Asia Pacific Sexually Transmitted Diseases Diagnostics Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Sexually Transmitted Diseases Diagnostics Markets in 2024
10.2 Asia Pacific Sexually Transmitted Diseases Diagnostics Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Sexually Transmitted Diseases Diagnostics Market size Outlook by Segments, 2021-2030
By Disease
CT/NG
Gonorrhea
HIV/AIDS
Genital Herpes
Hepatitis B
Syphilis
Mycoplasma Genitalium
Genital Warts
Candidal Vaginitis
Trichomoniasis
Bacterial Vaginosis
HPV
Others
By Test
Culture/Isolation Of Organisms
Molecular Test
Immunology Assay
Others
By Device
Laboratory Devices
-Thermal Cyclers – PCR
-Lateral Flow Readers
-Flow Cytometers
-Absorbance Microplate Reader
-Differential Light Scattering Machines
Point Of Care (Poc) Devices
-Phone Chips (Microfluidics + ICT)
-Portable/Bench Top/Rapid Diagnostic Kits
By End-User
Laboratory
-Commerical/Private Labs
-Public Health Labs
Point of Care (POC)
11 South America Sexually Transmitted Diseases Diagnostics Market Analysis and Outlook To 2030
11.1 Introduction to South America Sexually Transmitted Diseases Diagnostics Markets in 2024
11.2 South America Sexually Transmitted Diseases Diagnostics Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Sexually Transmitted Diseases Diagnostics Market size Outlook by Segments, 2021-2030
By Disease
CT/NG
Gonorrhea
HIV/AIDS
Genital Herpes
Hepatitis B
Syphilis
Mycoplasma Genitalium
Genital Warts
Candidal Vaginitis
Trichomoniasis
Bacterial Vaginosis
HPV
Others
By Test
Culture/Isolation Of Organisms
Molecular Test
Immunology Assay
Others
By Device
Laboratory Devices
-Thermal Cyclers – PCR
-Lateral Flow Readers
-Flow Cytometers
-Absorbance Microplate Reader
-Differential Light Scattering Machines
Point Of Care (Poc) Devices
-Phone Chips (Microfluidics + ICT)
-Portable/Bench Top/Rapid Diagnostic Kits
By End-User
Laboratory
-Commerical/Private Labs
-Public Health Labs
Point of Care (POC)
12 Middle East and Africa Sexually Transmitted Diseases Diagnostics Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Sexually Transmitted Diseases Diagnostics Markets in 2024
12.2 Middle East and Africa Sexually Transmitted Diseases Diagnostics Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Sexually Transmitted Diseases Diagnostics Market size Outlook by Segments, 2021-2030
By Disease
CT/NG
Gonorrhea
HIV/AIDS
Genital Herpes
Hepatitis B
Syphilis
Mycoplasma Genitalium
Genital Warts
Candidal Vaginitis
Trichomoniasis
Bacterial Vaginosis
HPV
Others
By Test
Culture/Isolation Of Organisms
Molecular Test
Immunology Assay
Others
By Device
Laboratory Devices
-Thermal Cyclers – PCR
-Lateral Flow Readers
-Flow Cytometers
-Absorbance Microplate Reader
-Differential Light Scattering Machines
Point Of Care (Poc) Devices
-Phone Chips (Microfluidics + ICT)
-Portable/Bench Top/Rapid Diagnostic Kits
By End-User
Laboratory
-Commerical/Private Labs
-Public Health Labs
Point of Care (POC)
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
bioMérieux SA
Bi-Rad Laboratories Inc
Danaher Corp
DiaSorin S.p.A
F. Hoffmann-La Roche Ltd
Grifols S.A.
Hologic Inc
QIAGEN NV
Quidel Corp
Thermo Fisher Scientific Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Disease
CT/NG
Gonorrhea
HIV/AIDS
Genital Herpes
Hepatitis B
Syphilis
Mycoplasma Genitalium
Genital Warts
Candidal Vaginitis
Trichomoniasis
Bacterial Vaginosis
HPV
Others
By Test
Culture/Isolation Of Organisms
Molecular Test
Immunology Assay
Others
By Device
Laboratory Devices
-Thermal Cyclers – PCR
-Lateral Flow Readers
-Flow Cytometers
-Absorbance Microplate Reader
-Differential Light Scattering Machines
Point Of Care (Poc) Devices
-Phone Chips (Microfluidics + ICT)
-Portable/Bench Top/Rapid Diagnostic Kits
By End-User
Laboratory
-Commerical/Private Labs
-Public Health Labs
Point of Care (POC)
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
